Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Differential CpG methylation of the promoter of interleukin 8 and the first intron of tissue factor in Antiphospholipid syndrome.

Patsouras MD, Karagianni P, Kogionou P, Vlachoyiannopoulos PG.

J Autoimmun. 2019 Aug;102:159-166. doi: 10.1016/j.jaut.2019.05.001. Epub 2019 May 15.

PMID:
31103268
2.

Pseudochylothorax in a Patient with Rheumatoid Arthritis.

Kampolis CF, Vlachoyiannopoulos PG.

J Rheumatol. 2019 Feb;46(2):213-214. doi: 10.3899/jrheum.180251. No abstract available.

PMID:
30710002
3.

How can autoantibodies predict the long-term outcome of patients with interstitial lung disease? Results from a retrospective cohort study.

Kampolis CF, Venetsanopoulou AI, Karakontaki F, Polychronopoulos V, Vlachoyiannopoulos P, Tzioufas AG.

Autoimmun Rev. 2018 Nov;17(11):1124-1133. doi: 10.1016/j.autrev.2018.06.004. Epub 2018 Sep 11.

PMID:
30213691
4.

Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.

Zampeli E, Venetsanopoulou A, Argyropoulou OD, Mavragani CP, Tektonidou MG, Vlachoyiannopoulos PG, Tzioufas AG, Skopouli FN, Moutsopoulos HM.

Clin Rheumatol. 2019 Jan;38(1):125-132. doi: 10.1007/s10067-018-4267-z. Epub 2018 Aug 25.

PMID:
30145635
5.

Postherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy.

Alexopoulos H, Akrivou S, Mastroyanni S, Antonopoulou M, Dinopoulos A, Giorgi M, Konstantinou K, Kouremenos E, Lariou M, Naoumis D, Pavlidou E, Pavlou E, Voudris K, Vlachoyiannopoulos P, Dalakas MC.

Ther Adv Neurol Disord. 2018 Apr 23;11:1756286418768778. doi: 10.1177/1756286418768778. eCollection 2018.

6.

The Role of Colchicine in the Treatment of Autoinflammatory Diseases.

Liantinioti G, Argyris AA, Protogerou AD, Vlachoyiannopoulos P.

Curr Pharm Des. 2018;24(6):690-694. doi: 10.2174/1381612824666180116095658.

PMID:
29336247
7.

Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study.

Fragoulis GE, Lionaki S, Venetsanopoulou A, Vlachoyiannopoulos PG, Moutsopoulos HM, Tzioufas AG.

Clin Rheumatol. 2018 Mar;37(3):737-747. doi: 10.1007/s10067-017-3835-y. Epub 2017 Sep 15.

PMID:
28914375
8.

Mapping and predicting mortality from systemic sclerosis.

Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airò P, Joven B, Vettori S, Cozzi F, Ullman S, Czirják L, Tikly M, Müller-Ladner U, Caramaschi P, Distler O, Iannone F, Ananieva LP, Hesselstrand R, Becvar R, Gabrielli A, Damjanov N, Salvador MJ, Riccieri V, Mihai C, Szücs G, Walker UA, Hunzelmann N, Martinovic D, Smith V, Müller CS, Montecucco CM, Opris D, Ingegnoli F, Vlachoyiannopoulos PG, Stamenkovic B, Rosato E, Heitmann S, Distler JHW, Zenone T, Seidel M, Vacca A, Langhe E, Novak S, Cutolo M, Mouthon L, Henes J, Chizzolini C, Mühlen CAV, Solanki K, Rednic S, Stamp L, Anic B, Santamaria VO, De Santis M, Yavuz S, Sifuentes-Giraldo WA, Chatelus E, Stork J, Laar JV, Loyo E, García de la Peña Lefebvre P, Eyerich K, Cosentino V, Alegre-Sancho JJ, Kowal-Bielecka O, Rey G, Matucci-Cerinic M, Allanore Y; EUSTAR group.

Ann Rheum Dis. 2017 Nov;76(11):1897-1905. doi: 10.1136/annrheumdis-2017-211448. Epub 2017 Aug 23.

PMID:
28835464
9.

Inflammation, DNA Damage, Helicobacter pylori and Gastric Tumorigenesis.

Kalisperati P, Spanou E, Pateras IS, Korkolopoulou P, Varvarigou A, Karavokyros I, Gorgoulis VG, Vlachoyiannopoulos PG, Sougioultzis S.

Front Genet. 2017 Feb 27;8:20. doi: 10.3389/fgene.2017.00020. eCollection 2017. Review.

10.

Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.

Sfikakis PP, Bournia VK, Sidiropoulos P, Boumpas DT, Drosos AA, Kitas GD, Konstantonis G, Liossis SN, Manoussakis MN, Sakkas L, Tektonidou M, Tzioufas AG, Vlachoyiannopoulos PG, Kani C, Paterakis P, Litsa P, Vassilopoulos D.

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):579-585. Epub 2017 Mar 3.

PMID:
28281458
11.

Cyclophosphamide followed by rituximab for aggressive multiple-relapsing antineutrophil cytoplasmic antibody-associated vasculitis.

Lionaki S, Fragoulis GE, Venetsanopoulou A, Vlachoyiannopoulos P, Boletis JN, Tzioufas AG.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):155-164. Epub 2017 Jan 25.

PMID:
28134075
12.

Treat-to-target biologic therapy in patients with rheumatoid arthritis is more efficacious and safe compared to delayed initiation of biologics: a real-world study.

Lampropoulos CE, Orfanos P, Manoussakis MN, Tzioufas AG, Moutsopoulos HM, Vlachoyiannopoulos PG.

Clin Exp Rheumatol. 2017 Mar-Apr;35(2):192-200. Epub 2017 Jan 16.

PMID:
28094760
13.

Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study.

Cutolo M, Herrick AL, Distler O, Becker MO, Beltran E, Carpentier P, Ferri C, Inanç M, Vlachoyiannopoulos P, Chadha-Boreham H, Cottreel E, Pfister T, Rosenberg D, Torres JV, Smith V; CAP Study Investigators.

Arthritis Rheumatol. 2016 Oct;68(10):2527-39. doi: 10.1002/art.39718.

14.

Osteoporosis and vascular calcification in postmenopausal women: a cross-sectional study.

Lampropoulos CE, Kalamara P, Konsta M, Papaioannou I, Papadima E, Antoniou Z, Andrianopoulou A, Vlachoyiannopoulos PG.

Climacteric. 2016 Jun;19(3):303-7. doi: 10.3109/13697137.2016.1164134. Epub 2016 Apr 5.

PMID:
27045323
15.

Treatment of rheumatoid arthritis: Unraveling the conundrum.

Zampeli E, Vlachoyiannopoulos PG, Tzioufas AG.

J Autoimmun. 2015 Dec;65:1-18. doi: 10.1016/j.jaut.2015.10.003. Epub 2015 Oct 27. Review.

PMID:
26515757
16.

Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome.

Patsouras MD, Sikara MP, Grika EP, Moutsopoulos HM, Tzioufas AG, Vlachoyiannopoulos PG.

J Autoimmun. 2015 Dec;65:30-7. doi: 10.1016/j.jaut.2015.08.001. Epub 2015 Aug 15.

PMID:
26283469
17.

Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world study.

Lampropoulos CE, Orfanos P, Bournia VK, Karatsourakis T, Mavragani C, Pikazis D, Manoussakis MN, Tzioufas AG, Moutsopoulos HM, Vlachoyiannopoulos PG.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2):216-24. Epub 2015 Feb 9.

PMID:
25664400
18.

Intact calibers of retinal vessels in patients with systemic sclerosis.

Aissopou EK, Bournia VK, Protogerou AD, Panopoulos S, Papaioannou TG, Vlachoyiannopoulos PG, Matucci-Cerinic M, Sfikakis PP.

J Rheumatol. 2015 Apr;42(4):608-13. doi: 10.3899/jrheum.141425. Epub 2015 Feb 1.

PMID:
25641886
19.

Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: a controlled study.

Kosmidis ML, Koutsogeorgopoulou L, Alexopoulos H, Mamali I, Vlachoyiannopoulos PG, Voulgarelis M, Moutsopoulos HM, Tzioufas AG, Dalakas MC.

J Neurol Sci. 2014 Dec 15;347(1-2):143-7. doi: 10.1016/j.jns.2014.09.035. Epub 2014 Sep 28.

PMID:
25304055
20.

Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and/or antiphospholipid syndrome: a 10-year follow-up study.

Kampolis C, Tektonidou M, Moyssakis I, Tzelepis GE, Moutsopoulos H, Vlachoyiannopoulos PG.

Semin Arthritis Rheum. 2014 Feb;43(4):558-65. doi: 10.1016/j.semarthrit.2013.07.016. Epub 2013 Sep 5.

PMID:
24012042
21.

Virus infection and autoimmunity: is there a cause-and-effect relationship?

Magira EE, Pitsolis T, Delimpasi S, Vourlakou C, Vlachoyiannopoulos P, Zakynthinos S.

J Clin Virol. 2014 Mar;59(3):137-40. doi: 10.1016/j.jcv.2013.08.002. Epub 2013 Aug 12. No abstract available.

PMID:
23994112
22.

Control of relapsed germ cell tumor and SLE nephritis by high-dose chemotherapy and autologous hematopoietic cell transplantation.

Kosmas C, Papachrysanthou T, Daladimos T, Athanasopoulos A, Tsavaris N, Vlachoyiannopoulos PG.

Future Oncol. 2013 Sep;9(9):1401-6. doi: 10.2217/fon.13.70.

PMID:
23980687
23.

Psychological characteristics of systemic sclerosis patients and their correlation with major organ involvement and disease activity.

Golemati CV, Moutsopoulos HM, Vlachoyiannopoulos PG.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):37-45. Epub 2013 Jul 22.

PMID:
23910608
24.

Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients.

Kampylafka EI, Alexopoulos H, Kosmidis ML, Panagiotakos DB, Vlachoyiannopoulos PG, Dalakas MC, Moutsopoulos HM, Tzioufas AG.

PLoS One. 2013;8(2):e55843. doi: 10.1371/journal.pone.0055843. Epub 2013 Feb 12.

25.

Dr. Vlachoyiannopoulos replies.

Vlachoyiannopoulos PG.

J Rheumatol. 2013 Jan;40(1):90. No abstract available.

PMID:
23401875
26.

Anticentromere (ACA)-positive Sjӧgren's syndrome: a disease entity?

Vlachoyiannopoulos PG, Moutsopoulos HM.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2):163-4. Epub 2013 Jan 23. No abstract available.

PMID:
23343831
27.

TGFβ receptor gene variants in systemic sclerosis-related pulmonary arterial hypertension: results from a multicentre EUSTAR study of European Caucasian patients.

Koumakis E, Wipff J, Dieudé P, Ruiz B, Bouaziz M, Revillod L, Guedj M, Distler JH, Matucci-Cerinic M, Humbert M, Riemekasten G, Airo P, Melchers I, Hachulla E, Cusi D, Wichmann HE, Hunzelmann N, Tiev K, Caramaschi P, Diot E, Kowal-Bielecka O, Cuomo G, Walker U, Czirják L, Damjanov N, Lupoli S, Conti C, Müller-Nurasyid M, Müller-Ladner U, Riccieri V, Cracowski JL, Cozzi F, Bournia VK, Vlachoyiannopoulos P, Chiocchia G, Boileau C, Allanore Y.

Ann Rheum Dis. 2012 Nov;71(11):1900-3. doi: 10.1136/annrheumdis-2012-201755. Epub 2012 Aug 15.

PMID:
22896741
28.

Factor XI is a substrate for oxidoreductases: enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis.

Giannakopoulos B, Gao L, Qi M, Wong JW, Yu DM, Vlachoyiannopoulos PG, Moutsopoulos HM, Atsumi T, Koike T, Hogg P, Qi JC, Krilis SA.

J Autoimmun. 2012 Sep;39(3):121-9. doi: 10.1016/j.jaut.2012.05.005. Epub 2012 Jun 13.

PMID:
22704541
29.

Subgroups of Sjögren syndrome patients according to serological profiles.

Bournia VK, Vlachoyiannopoulos PG.

J Autoimmun. 2012 Aug;39(1-2):15-26. doi: 10.1016/j.jaut.2012.03.001. Epub 2012 May 8. Review.

PMID:
22575069
30.

Sjogren's syndrome: an update on clinical, basic and diagnostic therapeutic aspects.

Tzioufas AG, Vlachoyiannopoulos PG.

J Autoimmun. 2012 Aug;39(1-2):1-3. doi: 10.1016/j.jaut.2012.01.006. Epub 2012 Feb 21.

PMID:
22361268
31.

Morbidity, mortality, and organ damage in patients with antiphospholipid syndrome.

Grika EP, Ziakas PD, Zintzaras E, Moutsopoulos HM, Vlachoyiannopoulos PG.

J Rheumatol. 2012 Mar;39(3):516-23. doi: 10.3899/jrheum.110800. Epub 2012 Jan 15.

PMID:
22247356
32.

Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I.

Ioannou Y, Zhang JY, Qi M, Gao L, Qi JC, Yu DM, Lau H, Sturgess AD, Vlachoyiannopoulos PG, Moutsopoulos HM, Rahman A, Pericleous C, Atsumi T, Koike T, Heritier S, Giannakopoulos B, Krilis SA.

Arthritis Rheum. 2011 Sep;63(9):2774-82. doi: 10.1002/art.30383.

33.

Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma.

Danielides S, Mavragani CP, Katsakoulas I, Zintzaras E, Drosos AA, Vlachoyiannopoulos PG, Moutsopoulos HM.

Scand J Rheumatol. 2011;40(4):299-303. doi: 10.3109/03009742.2010.549837. Epub 2011 Mar 21.

PMID:
21417550
34.

A novel mechanism of thrombosis in antiphospholipid antibody syndrome.

Vlachoyiannopoulos PG, Routsias JG.

J Autoimmun. 2010 Nov;35(3):248-55. doi: 10.1016/j.jaut.2010.06.015. Epub 2010 Jul 16. Review.

PMID:
20638238
35.

Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database.

Avouac J, Walker U, Tyndall A, Kahan A, Matucci-Cerinic M, Allanore Y; EUSTAR, Miniati I, Muller A, Iannone F, Distler O, Becvar R, Sierakowsky S, Kowal-Bielecka O, Coelho P, Cabane J, Cutolo M, Shoenfeld Y, Valentini G, Rovensky J, Riemekasten G, Vlachoyiannopoulos P, Caporali R, Jiri S, Inanc M, Zimmermann Gorska I, Carreira P, Novak S, Czirjak L, Oliveira Ramos F, Jendro M, Chizzolini C, Kucharz EJ, Richter J, Cozzi F, Rozman B, Mallia CM, Gabrielli A, Farge D, Kiener HP, Schöffel D, Airo P, Wollheim F, Martinovic D, Trotta F, Jablonska S, Reich K, Bombardieri S, Siakka P, Pellerito R, Bambara LM, Morovic-Vergles J, Denton C, Hinrichs R, Van den Hoogen F, Damjanov N, Kötter I, Ortiz V, Heitmann S, Krasowska D, Seidel M, Hasler P, Van Laar JM, Kaltwasser JP, Foeldvari I, Juan Mas A, Bajocchi G, Wislowska M, Pereira Da Silva JA, Jacobsen S, Worm M, Graniger W, Kuhn A, Stankovic A, Cossutta R, Majdan M, Damjanovska Rajcevska L, Tikly M, Nasonov EL, Steinbrink K, Herrick A, Müller-Ladner U, Dinc A, Scorza R, Sondergaard K, Indiveri F, Nielsen H, Szekanecz Z, Silver RM, Antivalle M, Espinosa IB, García de la Pena Lefebvre P, Midtvedt O, Launay D, Valesini F, Tuvik P, Ionescu RM, Del Papa N, Pinto S, Wigley F, Mihai C, Sinziana Capranu M, Sunderkötter C, Jun JB, Alhasani S, Distler JH, Ton E, Soukup T, Seibold J, Zeni S, Nash P, Mouthon L, De Keyser F, Duruöz MT, Cantatore FP, Strauss G, von Mülhen CA, Pozzi MR, Eyerich K, Szechinski J, Keiserman M, Houssiau FA, Román-Ivorra JA, Krummel-Lorenz B, Aringer M, Westhovens R, Bellisai F, Mayer M, Stoeckl F, Uprus M, Volpe A, Buslau M, Yavuz S, Granel B, Valderílio Feijó A, Del Galdo F, Popa S, Zenone T, Ricardo Machado X, Pileckyte M, Stebbings S, Mathieu A, Tulli A, Tourinho T, Souza R, Acayaba de Toledo R, Stamp L, Solanki K, Veale D, Francisco Marques Neto J, Bagnato GF, Loyo E, Toloza S, Li M, Ahmed Abdel Atty Mohamed W, Cobankara V, Olas J, Salsano F, Oksel F, Tanaseanu CM, Foti R, Ancuta C, Vonk M, Caramashi P, Beretta L, Balbir A, Chiàla A, Pasalic Simic K, Ghio M, Stamenkovic B, Rednic S, Host N, Pellerito R, Hachulla E, Furst DE.

J Rheumatol. 2010 Jul;37(7):1488-501. doi: 10.3899/jrheum.091165. Epub 2010 Jun 15.

PMID:
20551097
36.

Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus.

Nossent J, Kiss E, Rozman B, Pokorny G, Vlachoyiannopoulos P, Olesinska M, Marchesoni A, Mosca M, Påi S, Manger K, Schneider M, Nielsen H, van Vollenhoven R, Swaak T.

Lupus. 2010 Jul;19(8):949-56. doi: 10.1177/0961203310366572. Epub 2010 Apr 7.

PMID:
20375124
37.

Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis.

Bournia VK, Diamanti KD, Vlachoyiannopoulos PG, Moutsopoulos HM.

Arthritis Res Ther. 2010;12(2):R47. doi: 10.1186/ar2958. Epub 2010 Mar 13.

38.

{beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome.

Sikara MP, Routsias JG, Samiotaki M, Panayotou G, Moutsopoulos HM, Vlachoyiannopoulos PG.

Blood. 2010 Jan 21;115(3):713-23. doi: 10.1182/blood-2009-03-206367. Epub 2009 Oct 5.

39.

Antithyroid antibodies in antiphospholipid syndrome: prevalence and clinical associations.

Mavragani CP, Danielides S, Zintzaras E, Vlachoyiannopoulos PG, Moutsopoulos HM.

Lupus. 2009 Oct;18(12):1096-9. doi: 10.1177/0961203309106763.

PMID:
19762385
40.

Recent advances in the treatment of systemic sclerosis.

Bournia VK, Vlachoyiannopoulos PG, Selmi C, Moutsopoulos HM, Gershwin ME.

Clin Rev Allergy Immunol. 2009 Jun;36(2-3):176-200. doi: 10.1007/s12016-008-8114-x. Review.

PMID:
19132559
41.

Comparative qualitative and quantitative analysis of scleroderma (systemic sclerosis) serologic immunoassays.

Picha L, Pakas I, Guialis A, Moutsopoulos HM, Vlachoyiannopoulos PG.

J Autoimmun. 2008 Sep;31(2):166-74. doi: 10.1016/j.jaut.2008.07.001. Epub 2008 Aug 13.

PMID:
18703312
42.

Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.

Vlachoyiannopoulos PG, Toya SP, Katsifis G, Zintzaras E, Tzioufas AG, Moutsopoulos HM.

J Rheumatol. 2008 Sep;35(9):1768-75. Epub 2008 Jul 15.

PMID:
18634157
43.

The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis.

Kampolis C, Plastiras S, Vlachoyiannopoulos P, Moyssakis I, Tzelepis G.

Scand J Rheumatol. 2008 Jul-Aug;37(4):278-83. doi: 10.1080/03009740801978871.

PMID:
18612928
44.

Severe reversible right heart failure in a patient with hyperthyroidism.

Syriou V, Plastiras SC, Paterakis T, Moyssakis I, Vlachoyiannopoulos P.

Int J Clin Pract. 2008 Feb;62(2):334-6. doi: 10.1111/j.1742-1241.2006.00979.x. No abstract available. Erratum in: Int J Clin Pract. 2008 May;62(5):841.

PMID:
18199280
45.

Determinants of pulmonary function improvement in patients with scleroderma and interstitial lung disease.

Tzelepis GE, Plastiras SC, Karadimitrakis SP, Vlachoyiannopoulos PG.

Clin Exp Rheumatol. 2007 Sep-Oct;25(5):734-9.

PMID:
18078622
46.

Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual.

Nossent J, Cikes N, Kiss E, Marchesoni A, Nassonova V, Mosca M, Olesinska M, Pokorny G, Rozman B, Schneider M, Vlachoyiannopoulos PG, Swaak A.

Lupus. 2007;16(5):309-17.

PMID:
17576731
47.

Antiphospholipid antibodies: laboratory and pathogenetic aspects.

Vlachoyiannopoulos PG, Samarkos M, Sikara M, Tsiligros P.

Crit Rev Clin Lab Sci. 2007;44(3):271-338. Review.

PMID:
17453920
48.

Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen.

Siapka S, Patrinou-Georgoula M, Vlachoyiannopoulos PG, Guialis A.

Autoimmunity. 2007 May;40(3):223-33.

PMID:
17453722
49.

Glucocorticoid receptor, nuclear factor kappaB, activator protein-1 and C-jun N-terminal kinase in systemic lupus erythematosus patients.

Oikonomidou O, Vlachoyiannopoulos PG, Kominakis A, Kalofoutis A, Moutsopoulos HM, Moutsatsou P.

Neuroimmunomodulation. 2006;13(4):194-204. Epub 2007 Mar 7.

PMID:
17347585
50.

Catastrophic antiphospholipid syndrome with heart involvement: diagnostic utility of the cardiac MRI.

Plastiras SC, Tzelepis GE, Kelekis NL, Vlachoyiannopoulos PG.

Int J Cardiol. 2007 Mar 2;116(1):e29-31. Epub 2006 Nov 20. No abstract available.

PMID:
17113663

Supplemental Content

Loading ...
Support Center